Global Health & Biotech Archives | Page 64 of 292 | Be Korea-savvy

Archive by category Global Health & Biotech

Policymakers Should Recognise #SelfCareIsHealthcare in Campaign Bid to Address Global Health Challenges

Policymakers Should Recognise #SelfCareIsHealthcare in Campaign Bid to Address Global Health Challenges

Self-care describes the role of individuals in preventing disease, promoting and maintaining their mental and physical health, and actively participating in their healthcare A wealth of evidence demonstrates the significant value of self-care to individuals, health systems, society and the economy Despite this, self-care is not universally viewed or understood as a healthcare intervention and [...]

Tealium for Healthcare Enables Enterprises to Establish Digital Trust with Patients and Physicians

Tealium for Healthcare Enables Enterprises to Establish Digital Trust with Patients and Physicians

Through the power of data, Tealium’s new solution solves healthcare companies’ biggest CX and regulatory compliance challenges San Diego, July 23, 2024 (Korea Bizwire) – Tealium, the largest independent and most trusted customer data platform (CDP), has released Tealium for Healthcare, a new solution that empowers healthcare organizations with stronger data governance, allowing them to gain deeper [...]

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate

VANCOUVER, British Columbia, July 22, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for ZW191, [...]

Invitation – Ascom Half-Year Results Conference 2024

Invitation – Ascom Half-Year Results Conference 2024

Ladies and Gentlemen, We cordially invite you to the online Half-Year Results Conference 2024 of Ascom Holding AG. There are two ways to participate in our conference: A conference call will be set up where analysts and media representatives can ask questions after the presentation. In addition, a live audio webcast with synchronized presentation slides including Q&A will be available.  Date: Tuesday 6 August [...]

First Half of 2024: Boehringer Ingelheim Progresses Pipeline at Pace and Reaches Major Milestones

First Half of 2024: Boehringer Ingelheim Progresses Pipeline at Pace and Reaches Major Milestones

Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosis Strong first half net sales growth of 7.4%* year on year Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported on Thursday significant progress in its pipeline across key therapeutic areas as it [...]

Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma

Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma

SHANGHAI, July 17, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has accepted for review the supplemental new drug application (sNDA) for toripalimab (trade name: [...]

Invixium Acquires Triax Technologies to Expand its Biometric Solutions with AI-based RTLS Offering for Improved Safety and Productivity at Industrial Sites and Critical Infrastructure

Invixium Acquires Triax Technologies to Expand its Biometric Solutions with AI-based RTLS Offering for Improved Safety and Productivity at Industrial Sites and Critical Infrastructure

TORONTO, July 17, 2024 (Korea Bizwire) –  Invixium, a global leader in biometric access control, workforce, and visitor management solutions, proudly announces its acquisition of US-based Triax Technologies (Triax). This strategic acquisition expands Invixium’s portfolio with Triax’s AI-based RTLS (Real-Time Location Systems) and connected worker solutions, designed to improve worker productivity and equipment utilization. With this move, [...]

Bon Secours Mercy Health and Philips Sign Multi-year Strategic Collaboration

Bon Secours Mercy Health and Philips Sign Multi-year Strategic Collaboration

July 17, 2024 Patient monitoring platform to deliver tools and time to help patients across 40+ care sites Amsterdam, the Netherlands, and Cincinnati, Ohio – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and Bon Secours Mercy Health (BSMH), one of the nation’s largest Catholic health systems, today announced a multi-year strategic collaboration for patient [...]

Io Therapeutics, Inc., Presented Today Results from Studies of IRX4204, the Company’s Phase II Clinical Development Stage, Highly Selective RXR Nuclear Receptor Agonist Compound, Supporting Its Potential Use for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Io Therapeutics, Inc., Presented Today Results from Studies of IRX4204, the Company’s Phase II Clinical Development Stage, Highly Selective RXR Nuclear Receptor Agonist Compound, Supporting Its Potential Use for Treatment of Amyotrophic Lateral Sclerosis (ALS)

SPRING, Texas, July 16, 2024 (Korea Bizwire) – Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis (ALS). The presentation titled “The RXR Nuclear Receptor Agonist Compound IRX4204 is a [...]

NetSfere Integrates Microsoft Nuance’s Dragon Medical Speech Recognition Into Its Secure Messaging Platform, Empowering Healthcare Professionals With Unmatched Compliance and Security

NetSfere Integrates Microsoft Nuance’s Dragon Medical Speech Recognition Into Its Secure Messaging Platform, Empowering Healthcare Professionals With Unmatched Compliance and Security

NetSfere Introduces Hands-Free Speech-to-Text Feature Enabling Efficient and Secure Communication of Medical Jargon for Healthcare Professionals CHICAGO, July 16, 2024 (Korea Bizwire) – NetSfere, a global provider of next-generation secure and compliant messaging and mobility solutions, today reaffirms its  collaboration with Microsoft and Nuance technology to equip healthcare organizations and professionals with encrypted and compliant communications [...]